α-Tocopherol and β-Carotene Concentrations in Legume-Grass Mixtures as Affected by Wilting and Ensiling

Fresh or preserved forage is the largest source of natural α-tocopherol and β-carotene for dairy cows. Plant species, wilting and method of preservation can affect the vitamin content of forage and, consequently, have a large impact on the concentrations of these vitamins in plasma of dairy cows (Agabriel et al.2007). The aim of this study was to determine the effects of species mixture, wilting, ensiling and additive on the contents of α-tocopherol and β-carotene in legume-grass forages

Variations an α-Tocopherol and β-Carotene Concentrations in Forage Legumes and Grasses Harvested at Different Sites and Maturity Stages

Forage is a major source of natural α-tocopherol and β-carotene for dairy cows. This study examined vitamin concentrations of birdsfoot trefoil (Bft), red clover (Rc), timothy (Ti) and meadow fescue (Mf) at different sites, years and cutting dates. Mixtures of Bft+Ti, Rc+Ti and Rc+Mf were established at Skara (58°21’N; 13°08’E) and Umeå (63°45’N; 20°17’E) in Sweden. First-year leys were cut on three occasions in spring (Umeå 2005, Skara 2005 and 2007); one week before heading of timothy, at heading and one week after heading. Birdsfoot trefoil had higher α-tocopherol concentration at Skara than at Umeå in the first two cuts in 2005 (66 vs. 27 and 50 vs. 36 mg/kg DM, respectively) and had generally higher concentration than Rc. α-Tocopherol concentrations of Bft and Rc were 32 vs. 17 and 50 vs. 25 mg/kg DM at Umeå and Skara 2005, respectively, averaged over cuts. At Skara, α-tocopherol concentration decreased with later cutting date of Bft and grasses (P \u3c 0.01). Birdsfoot trefoil had higher β-carotene concentration at Skara than at Umeå in 2005 (70 vs. 55 mg/kg DM) and higher concentration than Rc at Skara, when averaged over cuts (70 vs. 46 mg/kg DM in 2005 and 82 vs. 52 in 2007; P = 0.037). Grasses had higher α-tocopherol and β-carotene concentrations at Skara than at Umeå in 2005, when averaged over cuts (56 vs. 33 and 46 vs. 23 mg/kg DM; P \u3c 0.001). Interactions between site, species and cutting date affected α-tocopherol and β-carotene concentrations in forages

The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors

BACKGROUND: Overexpression of the human epidermal growth factor receptor (HER) 2 is associated with poor prognosis and shortened survival in breast cancer patients. HER2 is a potent activator of several signaling pathways that support cell survival, proliferation and metabolism. In HER2-positive breast cancer there are most likely unexplored proteins that act directly or indirectly downstream of well established pathways and take part in tumor development and treatment response. METHODS: In order to identify novel copy number variations (CNVs) in HER2-positive breast cancer whole-genome single nucleotide polymorphism (SNP) arrays were used. A PCR-based loss of heterozygosis (LOH) assay was conducted to verify presence of deletion in HER2-positive breast cancer cases but also in HER2 negative breast cancers, cervical cancers and lung cancers. Screening for mutations was performed using single-strand conformation polymorphism (SSCP) followed by PCR sequencing. Protein expression was evaluated with immunohistochemistry (IHC). RESULTS: A common deletion at chromosome Xq24 was found in 80% of the cases. This locus harbors the gene solute carrier (SLC) family 25A member 43 (SLC25A43) encoding for a mitochondrial transport protein. The LOH assay revealed presence of SLC25A43 deletion in HER2-positive (48%), HER2-negative (9%), cervical (42%) and lung (67%) cancers. HER2-positive tumors with negative or low SLC25A43 protein expression had significantly lower S-phase fraction compared to tumors with medium or high expression (P = 0.024). CONCLUSIONS: We have found deletion in the SLC25A43 gene to be a common event in HER2-positive breast cancer as well as in other cancers. In addition, the SLC25A43 protein expression was shown to be related to S-phase fraction in HER2-positive breast cancer. Our results indicate a possible role of SLC25A43 in HER2-positive breast cancer and support the hypothesis of altered mitochondrial function in cancer

Indflydelse af høstmetode og konservering på vitamin- og fedtsyreindhold

I FØJO III projektet ECOVIT undersøges det, i hvilket omfang det er muligt at optimere vitaminindholdet i grovfoderafgrøderne ved at foretage det optimale valg af afgrøder, høsttidspunkt, forvejring og lagerform. I projektet har vi undersøgt forskellige græsmarksafgrøder dyrket i både Danmark og Sverige og sammenholdt resultaterne fra de to lande. Resultaterne viser, at der er betydelige forskelle i vitaminindholdet mellem afgrøder og hen over dyrkningssæsonen. Generelt har bladrige grønne afgrøder det højeste vitaminindhold. Tabet under forvejring og lagring varierer også ganske betydeligt, og det er vanskeligt at give præcise retningslinjer for, hvordan dette tab minimeres mest muligt. Det ser dog ud til, at en lang forvejringsperiode øger tabet, og det kan således forklare det lave indhold i hø af såvel vitaminer som fedtsyrer

Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis

ABSTRACT: INTRODUCTION: Change in bone mineral density (BMD) in the hand, as evaluated by digital X-ray radiogrammetry (DXR) of the II-IV metacarpal bones, has been suggested to predict future joint damage in rheumatoid arthritis (RA). This study's objective was to investigate if DXR-BMD loss early in the disease predicts development of joint damage in RA patients followed for up to 20 years. METHODS: 183 patients (115 women and 68 men) with early RA (mean disease duration 11 months) included from 1985 to 1989 were followed prospectively (the Lund early RA cohort). Clinical and functional measures were assessed yearly. Joint damage was evaluated according to the Larsen score on radiographs of hands and feet taken in years 0 to 5, 10, 15 and 20. These radiographs were digitized and BMD of the II-IV metacarpal bones was evaluated by DXR (Sectra, Linkoping. Sweden). Early DXR-BMD change rate (bone loss) per year calculated from the first 2 radiographs taken on average 9 months apart (SD 4.8) were available for 135 patients. Mean values of right and left hand were used. RESULTS: Mean early DXR-BMD loss during the first year calculated was -0.023 g/cm2 (SD 0.025). Patients with marked bone loss, i.e. early DXR-BMD loss above the median for the group, had significantly worse progression of joint damage at all examinations during the 20-year period. CONCLUSIONS: Early DXR-BMD progression rate predicted development of joint damage evaluated according to Larsen at year one and further onwards up to 20 years in this cohort of early RA patients

The human long non-coding RNA gene RMRP has pleiotropic effects and regulates cell-cycle progression at G2

RMRP was the first non-coding nuclear RNA gene implicated in a disease. Its mutations cause cartilage-hair hypoplasia (CHH), an autosomal recessive skeletal dysplasia with growth failure, immunodeficiency, and a high risk for malignancies. This study aimed to gain further insight into the role of RNA Component of Mitochondrial RNA Processing Endoribonuclease (RMRP) in cellular physiology and disease pathogenesis. We combined transcriptome analysis with single-cell analysis using fibroblasts from CHH patients and healthy controls. To directly assess cell cycle progression, we followed CHH fibroblasts by pulse-labeling and time-lapse microscopy. Transcriptome analysis identified 35 significantly upregulated and 130 downregulated genes in CHH fibroblasts. The downregulated genes were significantly connected to the cell cycle. Multiple other pathways, involving regulation of apoptosis, bone and cartilage formation, and lymphocyte function, were also affected, as well as PI3K-Akt signaling. Cell-cycle studies indicated that the CHH cells were delayed specifically in the passage from G2 phase to mitosis. Our findings expand the mechanistic understanding of CHH, indicate possible pathways for therapeutic intervention and add to the limited understanding of the functions of RMRP.Peer reviewe

Rheumatoid Arthritis in a 10-Year Perspective, Outcome for Patients Followed from Early Disease

Rheumatoid arthritis (RA) is characterized by persistent inflammation, progressive joint damage and disability. This thesis describes the outcome after 10 years in a cohort of 183 RA patients (116 women, 67 men) recruited 1985-89. The mean age was 51 years and symptom duration 11 months at inclusion. Standardized clinical, biochemical and radiographic assessments were performed annually. Health status, disease process, damage and mortality were evaluated and early factors predicting outcome were investigated. After 10 years: -94% preserved independence in daily life, 47% were mildly disabled, as evaluated by HAQ, however disability increased significantly. -18% were in remission, 17% had undergone large joint replacement and 8% had developed extra-articular manifestations. -Joint damage in hands and feet developed and progressed most markedly during the first 3 years and affected 96% of the patients. -Mortality was not increased. -Initial HAQ predicted disability after 10 years correctly to 70%, while remission, extra-articular manifestations and mortality were not predictable. -ESR, COMP, IgA-RF, anti-CCP and anti-IL-1alpha at inclusion were prognostic for future joint damage in an additive fashion. -In the disablement process, disease activity and joint damage contributed most to the development of body function impairments. Disease activity and body function impairments subsequently led to activity limitations (HAQ). The outcome has improved compared with earlier studies, especially for disability and mortality. Continued follow-up of these patients will provide information on the long-term consequences of RA and the cohort will be useful for the evaluation of novel prognostic markers

Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.

Objective: To investigate the mortality rate and possible early predictive factors of mortality after 19-23 years in a cohort of patients with rheumatoid arthritis (RA) followed prospectively from disease onset. Patients and methods: A community-based cohort of 183 patients (63% female) with RA and disease duration < 2 years was recruited 1985-1989. The patients were followed yearly from diagnosis until death or 31 December 2008. Mean age and mean duration of symptoms (range) at diagnosis were 52 (18-78) years and 11 (0-24) months, respectively. Death certificates were obtained from the Swedish Cause of Death Register and causes of death were coded by the International Classification of Diseases (ICD-10). Death rates of RA patients were compared to those of age- and sex-matched controls. Possible predictors of mortality were analysed using a Cox regression model. Results: By 31 December 2008, 69 patients (37 women and 32 men) had died. The standardized mortality ratio (SMR) was 1.23 [95% confidence interval (CI) 0.97-1.55] and p < 0.09. Older age, male sex, smoking, and the presence of cardiovascular disease (CVD) at RA diagnosis were identified as early predictors of mortality. CVD was the most common cause of death (46%), followed by malignancies (29%) and infections (13%). RA was not stated as the direct cause of death in any patient and was mentioned among underlying causes in only 16/69 (23%) patients. Conclusion: Mortality rate after 19-23 years of disease duration in this cohort of patients with disease onset in the 1980s was not significantly increased compared to age- and sex-matched controls. No RA disease-related factor predicted mortality

Prevalence of chronic widespread pain in a population-based cohort of patients with spondyloarthritis – a cross-sectional study

Abstract Background Chronic pain, regional or widespread, is a frequent and multidimensional symptom in arthritis. There is still limited information on chronic pain in spondyloarthritis, which is important to recognize for adequate diagnosis and treatment. Our objective was to study differences in prevalence of chronic widespread pain in two spondyloarthritis subgroups: ankylosing spondylitis (AS) and undifferentiated spondyloarthritis (USpA). Methods A population-based postal survey involving questions on the duration, distribution, and intensity of pain was answered by 940 patients with AS (ICD-10 M45.9) or USpA (ICD-10 M46.1-0, M46.8-9). The patients were categorized as having chronic widespread pain, chronic regional pain, or no chronic pain, and prevalence estimates for the pain groups were calculated, including age- and sex-adjusted prevalence. Results The prevalence of chronic widespread pain was 45.3% in AS vs. 49.3% in USpA, and that of chronic regional pain was 17.7% vs. 21.9% (p = 0.033). More women than men reported having chronic widespread pain (54.1% vs. 41.2%, p ≤ 0.001), while the sex distribution for chronic regional pain was equal. Reports of pain intensity were equal in AS and USpA, with no significant difference in pain intensity between women and men who had chronic regional pain or chronic widespread pain. In the multiple logistic regression analysis, chronic widespread pain was associated to female sex, being an ever-smoker, and having a higher body mass index, controlled for SpA subgroup and disease duration. Conclusions The prevalence of chronic widespread pain in patients with AS and USpA is high, and with a female predominance, but with no difference in pain intensity between women and men. Chronic pain can complicate the clinical evaluation in patients with SpA, and highlights the need for a thorough clinical examination, including evaluation of inflammation and an accurate pain analysis, to individualize non-pharmacological and pharmacological treatment decisions